U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT06909305) titled 'Effect of Intraarticular Ozone, Prolotherapy or Dexmedetomidine in Pain Limitation in Knee Osteoarthritis' on March 27.
Brief Summary: This study aimed to compare intraarticular ozone injection, prolotherapy, or dexmedetomidine effectiveness in knee osteoarthritis patients.
Study Start Date: Oct. 01, 2022
Study Type: INTERVENTIONAL
Condition:
Intraarticular
Ozone
Prolotherapy
Dexmedetomidine
Pain
Knee Osteoarthritis
Intervention:
DRUG: Ozone
Patients received intraarticular ozone injection.
DRUG: Dextrose prolotherapy
Patients received intraarticular dextrose prolotherapy injection.
DRUG: Dexmedetomidine
Patients received...